These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12402231)

  • 1. [Recent advances in the neuropathological evaluation of Alzheimer's disease: the importance of alpha-synuclein].
    Hamilton RL
    Rev Neurol; 2002 Oct 16-31; 35(8):765-7. PubMed ID: 12402231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.
    Hamilton RL
    Brain Pathol; 2000 Jul; 10(3):378-84. PubMed ID: 10885656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
    Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ
    Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
    Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.
    Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ
    Ann Neurol; 1999 Mar; 45(3):353-7. PubMed ID: 10072050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease.
    Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ
    Arch Neurol; 2001 Nov; 58(11):1817-20. PubMed ID: 11708989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease.
    Marui W; Iseki E; Uéda K; Kosaka K
    J Neurol Sci; 2000 Mar; 174(2):81-4. PubMed ID: 10727692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
    Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.
    Wirths O; Weickert S; Majtenyi K; Havas L; Kahle PJ; Okochi M; Haass C; Multhaup G; Beyreuther K; Bayer TA
    Neuroreport; 2000 Nov; 11(17):3737-41. PubMed ID: 11117482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red.
    Sakamoto M; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Mizusawa H; Hirai S
    Exp Neurol; 2002 Sep; 177(1):88-94. PubMed ID: 12429213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.